NDC 66621-0790

ANAVIP

Crotalidae Immune F(ab)2(equine)

ANAVIP is a Intravenous Injection, Powder, Lyophilized, For Solution in the Plasma Derivative category. It is labeled and distributed by Rare Disease Therapeutics, Inc. The primary component is Pit Viper (crotalinae) Immune Globulin Antivenin (equine).

Product ID66621-0790_21a8934a-617c-4c84-aa88-4907ab40ccd2
NDC66621-0790
Product TypePlasma Derivative
Proprietary NameANAVIP
Generic NameCrotalidae Immune F(ab)2(equine)
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2015-05-06
Marketing CategoryBLA / BLA
Application NumberBLA125488
Labeler NameRare Disease Therapeutics, Inc
Substance NamePIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE)
Active Ingredient Strength24 mg/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 66621-0790-2

1 VIAL in 1 CARTON (66621-0790-2) > 10 mL in 1 VIAL (66621-0790-1)
Marketing Start Date2015-05-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66621-0790-1 [66621079001]

ANAVIP INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA125488
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2015-05-06

NDC 66621-0790-2 [66621079002]

ANAVIP INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA125488
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2016-11-25

Drug Details

Active Ingredients

IngredientStrength
PIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE)24 mg/mL

Trademark Results [ANAVIP]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ANAVIP
ANAVIP
78825625 3506545 Live/Registered
LABORATORIOS SILANES S.A. DE C.V.
2006-02-28
ANAVIP
ANAVIP
78295398 not registered Dead/Abandoned
Pharmasil, Inc.
2003-09-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.